| Drug Name |
Dexmethylphenidate |
| Drug ID |
BADD_D02457 |
| Description |
Dexmethylphenidate is the dextrorotary form of methylphenidate introduced in 2002[A177181]. It is a norepinephrine-dopamine reuptake inhibitor (NDRI) and thus a psychostimulant[A177193]. It is used for treatment of Attention Deficit Hyperactivity Disorder (ADHD)[Label,A177181]. The d-isomer is thought to have greater effect with fewer side effects than the l-isomer or the racemic mixture[A177181]. |
| Indications and Usage |
Dexmethylphenidate is used as a treatment for ADHD, ideally in conjunction with psychological, educational, behavioral or other forms of treatment[A177187,Label]. |
| Marketing Status |
approved; investigational |
| ATC Code |
N06BA11 |
| DrugBank ID |
DB06701
|
| KEGG ID |
D07806
|
| MeSH ID |
D064699
|
| PubChem ID |
154101
|
| TTD Drug ID |
D02QCD
|
| NDC Product Code |
Not Available |
| UNII |
M32RH9MFGP
|
| Synonyms |
Dexmethylphenidate Hydrochloride | Hydrochloride, Dexmethylphenidate | Focalin XR | XR, Focalin | Dexmethylphenidate | Focalin |
